A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

The "Autism - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report outlays comprehensive insights of present clinical development scenario and growth ...

LP-184 Phase 1b/2 TNBC Trial Overview - Monotherapy The monotherapy ... and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR ...

The FDA has cleared the investigational new drug (IND) application of LP-184 in triple negative breast cancer (TNBC) treatment – a novel small molecule advanced and developed with Lantern’s AI ...

Quantum computing stands at the precipice of transforming our technological landscape. In 1981, Nobel Prize-winning physicist ...

Bristol Myers Squibb Co. About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key ...

Chlorella and spirulina are both algae, but spirulina is less expensive to process and often cheaper. Both have protein, but ...

One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they could imperil the drug approval process that has served as the global ...

Q1 2025 Earnings Call Transcript May 6, 2025 Evotec SE beats earnings expectations. Reported EPS is $-0.05152, expectations ...

Tim Zehring trailblazed an international crime-free movement starting in Mesa. He says he is not concerned if landlords abuse ...